2004•Zhongguo yiyuan yongyao pingjia yu fenxiRequires access

Cost-effectiveness Analysis of the Treatment of Functional Dyspepsia with 4 Treatment Projects

Bin Zhu

Abstract

OBJECTIVE:To compare the efficiency and pharmacoeconomic cost of mosapride, cisapride, clebopride and domperidone in the treatment of functional dyspepsia. METHODS:272 cases of functional dyspepsia were randomly divided into 4 groups:group A(mosapride 5mg, tid, po);group B(cisapride 10mg, tid, po);group C(clebopride 0.68mg,tid po) and group D(domperidone 10mg, tid,po). The course of treatment was 4 weeks. They were evaluated by cost-effectiveness analysis of pharmacoeconomics. RESULTS: The cost-effectiveness ratio of mosapride, cisapride, clebopride and domperidone for the treatment of functional dyspepsia was 1.05,2.24,1.49 and 0.85, respectively. CONCLUSION: Treatment project in group A will get best result.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Domperidone, Mosapride, Cisapride, Medicine, Pharmacoeconomics, Internal medicine, Gastroenterology, Intensive care medicine